Denosumab - PDFSEARCH.IO - Document Search Engine

Denosumab
Results: 175

#	Item
41	PATIENT INFORMATION ON BISPHOSPHONATES (INTRAVENOUS / IV) (Examples of brand names: Aclasta, Aredia) Add to Reading List Source URL: www.rheumatology.org.au Language: English - Date: 2014-03-20 02:10:37 Bisphosphonate Pharmacology Osteonecrosis of the jaw Osteoporosis Zoledronic acid Pamidronic acid Aclasta Denosumab Teriparatide Bisphosphonates Medicine Health
42	WHEN: The first Sydney Bone group meeting for 2015 will be held on Tuesday 7th April[removed]WHERE: The Macquarie Room, The Royal Australasian College of Physicians (RACP) 145 Macquarie Street, Sydney NSW, 2000 Please not Add to Reading List Source URL: www.anzbms.org.au Language: English - Date: 2015-02-22 23:13:23 University of New South Wales Pharmaceutical industry Amgen Denosumab Macquarie Street
43	PATIENT INFORMATION ON TERIPARATIDE (Brand name: Forteo) This information sheet has been produced by the Add to Reading List Source URL: www.rheumatology.org.au Language: English - Date: 2014-03-20 02:31:03 Health Drugs Osteopathies Chemistry Teriparatide Osteoporosis Alendronic acid Denosumab Aclasta Medicine Eli Lilly and Company Bisphosphonates
44	Microsoft Word - ANZBMS 2010 Draft Program V21.docx Add to Reading List Source URL: www.anzbms.org.au Language: English - Date: 2015-02-22 22:58:39 Skeletal system Traumatology Osteology Radiology Denosumab Osteoporosis Dual-energy X-ray absorptiometry Bone density Bone disease Medicine Health Osteopathies
45	PATIENT INFORMATION ON STRONTIUM (Brand name: Protos) This information sheet has been produced by Add to Reading List Source URL: www.rheumatology.org.au Language: English - Date: 2014-03-20 02:31:29 Bisphosphonates Alkaline earth metals Chemical elements Reducing agents Eli Lilly and Company Osteoporosis Strontium Alendronic acid Denosumab Chemistry Medicine Matter
46	1313 Final protocol to guide the assessment of bone mineral density analyses using Dual Energy X-Ray Absorptiometry (DXA) in breast cancer patients receiving aromatase inhibitor treatment July 2013 Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-10-27 00:28:02 Dual-energy X-ray absorptiometry Radiology Osteoporosis Bone density Aromatase inhibitor Peripheral quantitative computed tomography Tamoxifen Osteopenia Denosumab Medicine Bisphosphonates Ribbon symbolism
47	1316 Final decision analytic protocol (DAP) to guide the assessment of bone mineral density analyses using dual energy X-ray absorptiometry (DXA) for women and men aged[removed]years with risk factors for osteoporosis Jul Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-10-30 01:55:11 Dual-energy X-ray absorptiometry Bisphosphonates Osteoporosis Bone density Osteopenia Peripheral quantitative computed tomography Human skeleton FRAX Denosumab Medicine Health Radiology
48 $Aging-associated diseases / Eli Lilly and Company / Osteopathies / Osteoporosis / Teriparatide / Menopause / Scottish Medicines Consortium / Compression fracture / Denosumab / Medicine / Health / Drugs$	Scottish Medicines Consortium Teriparatide (Forsteo ) Eli Lilly (No[removed]) Add to Reading List Source URL: www.scottishmedicines.org.uk Language: English Aging-associated diseases Eli Lilly and Company Osteopathies Osteoporosis Teriparatide Menopause Scottish Medicines Consortium Compression fracture Denosumab Medicine Health Drugs
49	1248 Consultation Decision Analytic Protocol (DAP) to guide the assessment of bone mineral density analyses using dual energy X-ray absorptiometry (DXA) or quantitative computerised tomography (QCT) for men and women age Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-10-28 21:29:41 Osteology Dual-energy X-ray absorptiometry Radiology Osteoporosis Bone density Peripheral quantitative computed tomography Osteopenia Human skeleton Denosumab Medicine Osteopathies Drugs
50	1316 Consultation protocol to guide the assessment of bone mineral density analyses using Dual Energy X-Ray Absorptiometry (DXA) for women and men aged[removed]years with risk factors for osteoporosis August 2012 Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-10-30 01:55:10 Dual-energy X-ray absorptiometry Osteopathies Bisphosphonates Bone density Osteoporosis Peripheral quantitative computed tomography Osteopenia Denosumab Alendronic acid Medicine Radiology Drugs

UPDATE